A detailed history of Raymond James & Associates transactions in First Trust Nyse Arca Biotechn stock. As of the latest transaction made, Raymond James & Associates holds 80,158 shares of FBT stock, worth $13.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
80,158
Previous 111,199 27.91%
Holding current value
$13.3 Million
Previous $17.1 Million 27.81%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$141.52 - $156.4 $4.39 Million - $4.85 Million
-31,041 Reduced 27.91%
80,158 $12.3 Million
Q1 2024

Apr 22, 2024

SELL
$145.08 - $160.46 $2.01 Million - $2.23 Million
-13,879 Reduced 11.1%
111,199 $17.1 Million
Q4 2023

Jan 16, 2024

SELL
$132.5 - $158.45 $65,587 - $78,432
-495 Reduced 0.39%
125,078 $19.8 Million
Q3 2023

Oct 24, 2023

SELL
$145.69 - $157.89 $921,926 - $999,127
-6,328 Reduced 4.8%
125,573 $18.4 Million
Q2 2023

Jul 25, 2023

SELL
$151.19 - $159.79 $2.87 Million - $3.03 Million
-18,956 Reduced 12.57%
131,901 $20.2 Million
Q1 2023

Apr 14, 2023

BUY
$147.92 - $165.37 $240,813 - $269,222
1,628 Added 1.09%
150,857 $23.4 Million
Q4 2022

Feb 08, 2023

BUY
$142.0 - $159.04 $4.26 Million - $4.77 Million
29,981 Added 25.14%
149,229 $23 Million
Q3 2022

Oct 25, 2022

BUY
N/A
8,326 Added 7.51%
119,248 $15.7 Million
Q2 2022

Aug 12, 2022

SELL
N/A
-8,908 Reduced 7.43%
110,922 $15 Million
Q1 2022

May 11, 2022

SELL
N/A
-14,143 Reduced 10.56%
119,830 $17.9 Million
Q4 2021

Feb 08, 2022

SELL
N/A
-15,688 Reduced 10.48%
133,973 $21.7 Million
Q3 2021

Nov 02, 2021

SELL
N/A
-19,357 Reduced 11.45%
149,661 $24.9 Million
Q2 2021

Aug 11, 2021

SELL
N/A
-37,819 Reduced 18.28%
169,018 $29.2 Million
Q1 2021

May 14, 2021

SELL
N/A
-16,390 Reduced 7.34%
206,837 $33.2 Million
Q4 2020

Feb 12, 2021

SELL
N/A
-2,380 Reduced 1.05%
223,227 $37.5 Million
Q3 2020

Nov 04, 2020

BUY
N/A
5,017 Added 2.27%
225,607 $35.5 Million
Q2 2020

Jul 28, 2020

BUY
N/A
41,179 Added 22.95%
220,590 $37 Million
Q1 2020

Apr 21, 2020

BUY
N/A
16,688 Added 10.26%
179,411 $23.5 Million
Q4 2019

Feb 12, 2020

SELL
N/A
-8,673 Reduced 5.06%
162,723 $24.2 Million
Q3 2019

Nov 07, 2019

SELL
N/A
-197,324 Reduced 53.52%
171,396 $21.2 Million
Q2 2019

Aug 06, 2019

BUY
N/A
31,046 Added 9.19%
368,720 $51.9 Million
Q1 2019

May 06, 2019

BUY
N/A
32,363 Added 10.6%
337,674 $50.9 Million
Q4 2018

Feb 11, 2019

BUY
N/A
2,695 Added 0.89%
305,311 $37.9 Million
Q3 2018

Nov 14, 2018

BUY
N/A
158,596 Added 110.12%
302,616 $48 Million
Q2 2018

Aug 14, 2018

BUY
N/A
14,642 Added 11.32%
144,020 $20.2 Million
Q1 2018

May 14, 2018

BUY
N/A
26,131 Added 25.31%
129,378 $17.2 Million
Q4 2017

Feb 14, 2018

BUY
N/A
2,763 Added 2.75%
103,247 $12.9 Million
Q3 2017

Nov 13, 2017

BUY
N/A
23,389 Added 30.34%
100,484 $12.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
77,095
77,095 $8.79 Million

Others Institutions Holding FBT

About FIRST TRUST NYSE ARCA BIOTECHN


  • Ticker FBT
  • Sector ETFs
  • Industry ETFs
More about FBT
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.